Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

By Tedesco M.A.   Ratti G.   Di Salvo G.   Natale F.  

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Prevention of Nitrate Tolerance with Angiotensin II Receptor Type 1 Blocker in Patients with Stable Angina: Yet Another Failed Strategy to Prevent Tolerance

By Thadani Udho  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 339-342

Springer Publishing Company

Access to resources Recommend Favorite

Perindopril versus Angiotensin II Receptor Blockade in Hypertension and Coronary Artery Disease: Implications of Clinical Trials

By Brady Adrian J.B.  

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 149-161

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy: A Multicentre Prospective Observational Study

By Meno Hiroshi  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 171-178

Adis International

Access to resources Recommend Favorite

The angiotensin AT 1 receptor antagonist, losartan, induces barrel rotation in the rat

By Kawachi A.   Miyashita M.   Motoya T.   Yamada K.  

European Journal of Pharmacology, Vol. 363, Iss. 2, 1998-12 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite